News & Insights

Lonza and the next wave of healthcare solutions

May 5, 2026

Time to Read: 3:57 mins

Walter Scott’s John Rae assesses outsourced drugs manufacturer Lonza’s role in the healthcare ecosystem.

Key points:

Lonza’s role in the healthcare space is simliar to that of chip manufacturers in the semiconductor supply chain.
The company has high customer retention which creates resilient revenues.
It is investing heavily to support growth, including building manufacturing capacity in the US.
Walter Scott sees several quality healthcare businesses with high degrees of profitability, cash generation and low levels of debt.

3305309 Exp: 7 August 2026

Reports | Macroeconomic

Monthly Checkpoints

Checkpoints is a comprehensive monthly chartbook highlighting major top-of-mind themes that could shape financial markets in the near term. In addition to the broader macroeconomic discussion, Checkpoints delivers detailed views on major asset classes, including global equities, fixed income and real assets.

Chart of the Week | Macroeconomic

Resilient through uncertainty

U.S. policy uncertainty has remained elevated and consumer sentiment has weakened. Even so, the economy has stayed resilient, and because growth has held up better than sentiment and headlines suggest, we continue to forecast 2% U.S. growth in 2026, in line with trend.

Article | Macroeconomic

Fiscal dominance, inflation and the future of portfolio construction

The rules of the market may have changed. How should multi-asset investors respond?

Article | Macroeconomic

Infrastructure and real assets shine as inflation fears linger

As 2026 neared its mid-year point, concerns about the impact of geopolitical shocks on inflation and growth have lingered despite hopes for a scaling back in the Middle East conflict.